全球精神分裂症治疗市场 – 2028 年行业趋势及预测

精神分裂症治疗的市场分析和见解

预计精神分裂症治疗市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析该市场到 2028 年将达到 88.6 亿美元，并将在上述预测期内以 2.65% 的复合年增长率增长。

精神分裂症是一种慢性疾病，会对患者的生活方式产生不良影响。精神分裂症患者对现实的理解有异常。这种疾病会导致一系列行为变化，包括妄想和幻觉。精神分裂症治疗是一个终生过程，用于治疗精神分裂症的药物会控制患者的活动。

由于生活方式的改变，精神分裂症的发病率迅速增加，这是加剧精神分裂症治疗市场增长和需求的重要因素之一。此外，强劲的研发活动也有助于 2021 年至 2028 年预测期内全球市场的增长。此外，麻醉品、 酒精等各种成瘾的发病率迅速增加 ，寻求治疗的患者数量增加，对更好的医疗保健基础设施的需求不断增长，也促进了市场的增长。同样，老年人口的增加以及新药和新疗法的推出也推动了上述预测期内的市场增长。 医疗保健的快速发展 以及医生和患者对复杂疗法的高需求将进一步加速精神分裂症治疗市场的扩张，并为 2021 年至 2028 年预测期内的市场提供巨大的增长机会。

然而，研发和治疗的巨大成本以及医疗基础设施的缺乏将限制精神分裂症治疗市场的增长。相反，世界某些地区缺乏认知，这可能会对精神分裂症治疗市场的发展构成挑战。

This schizophrenia treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on schizophrenia treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Schizophrenia Treatment Market Scope and Market Size

Schizophrenia treatment market is segmented on the basis of therapeutic class, product type, treatment and end users. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• The therapeutic class segment of schizophrenia treatment market is segmented into third-generation antipsychotics, second-generation antipsychotics and others.
• On the basis of product type, the schizophrenia treatment market is segmented into medications, conventional or typical antipsychotic drugs, atypical antipsychotic drugs and therapies.
• Based on risk in treatment, the schizophrenia treatment market is segmented into oral and injectable.
• The end users segment of the schizophrenia treatment market is segmented into hospitals including hospital pharmacies, retail pharmacies and rehabilitation centers.

Schizophrenia Treatment Market Country Level Analysis

Schizophrenia treatment market is analyzed and market size insights and trends are provided by country, therapeutic class, product type, treatment and end users as referenced above.

The countries covered in the  schizophrenia treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the schizophrenia treatment market owing to the growing prevalence of schizophrenia, rising geriatric population and increasing demand for schizophrenia treatment within the region. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the rapidly increasing population and growing demand for technologically advanced treatments in this particular region.

The country section of the schizophrenia treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Schizophrenia treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for schizophrenia treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the schizophrenia treatment market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Schizophrenia Treatment Market Share Analysis

Schizophrenia treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to schizophrenia treatment market.

精神分裂症治疗市场报告涵盖的主要参与者包括强生服务公司、百时美施贵宝公司、大塚控股有限公司、阿斯利康、礼来公司、Alkermes、住友大日本制药有限公司、辉瑞公司、VANDA PHARMACEUTICALS、梅奥医学教育和研究基金会 (MFMER)、Allergan、H. Lundbeck A/S、AVINEURO PHARMACEUTICALS、Gedeon Richter plc、安斯泰来制药公司、诺华公司、艾伯维公司、PsychoGenics Inc. 和 Merz Pharma 等国内外参与者。市场份额数据分别提供全球、北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 和南美。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。 

SKU-27284